Skip to main content

GOLDMAN SACHS GROUP INC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 886982 NEW YORK, NY

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$68,777,123
+$47,333,746 QoQ
Shares Held
1,201,977
+216.6% QoQ
Ownership
0.621%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 561 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Jun 30, 2021
CallValue
$0
CallShares
0
PutValue
$7,342,720
PutShares
88,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. BMRN ranks #48 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BMRN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,777,123 1,201,977
2026-03-31 $21,443,377 379,596
2025-09-30 $124,078,393 2,290,960
2025-06-30 $115,745,105 2,105,605
2024-12-31 $33,486,213 509,451
2024-09-30 $31,628,108 449,966
2024-06-30 $46,088,497 559,802
2024-03-31 $60,546,182 693,224
2022-03-31 $54,634,446 708,618
2021-06-30 $7,342,720 88,000
2021-06-30 $104,394,953 1,251,138
2021-03-31 $6,644,880 88,000
2021-03-31 $91,581,697 1,212,842
2020-12-31 $140,827,508 1,605,970
2020-12-31 $11,005,095 125,500
2020-12-31 $4,402,038 50,200
2020-09-30 $4,184,400 55,000
2020-09-30 $127,972,113 1,682,073
2020-09-30 $5,896,200 77,500
2020-06-30 $235,393,155 1,908,490
2020-06-30 $308,350 2,500
2020-06-30 $9,558,850 77,500
2020-03-31 $142,171,841 1,682,507
2020-03-31 $4,858,750 57,500
2020-03-31 $7,816,250 92,500